Molecular Signalling Pathway Offers Hope for PN Patients

Have you been diagnosed with peripheral neuropathy? We can help.

Scientists at the University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba, and St. Boniface Hospital Albrechtsen Research Centre in Canada, say they have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy, and human immunodeficiency virus (HIV)-associated neuropathy.
close up view of a dna double helix, dna damage, concept of disorder or genetic mutation (3d render)

Their findings (“Selective Antagonism of Muscarinic Receptors Is Neuroprotective in Peripheral Neuropathy”) are published in the Journal of Clinical Investigation.

Peripheral neuropathy is a condition resulting from damage to the peripheral nervous system. Symptoms range from numbness, tingling, and muscle weakness to severe pain, paralysis, and organ dysfunction. An estimated 20 million Americans have some form of peripheral neuropathy, which can be a symptom of many diseases, including diabetes and HIV, or a side effect of some chemotherapies.

“Peripheral neuropathy is a major and largely untreated cause of human suffering,” said first author Nigel Calcutt, Ph.D., professor of pathology at UC San Diego School of Medicine. “It has huge associated healthcare costs.”

In their JCI paper, the researchers looked for key molecules and mechanisms used in sensory neuron growth and regrowth. In particular, they noted that the outgrowth of neurites, projections from a neuronal cell body that connect it to other neurons, was constrained by activation of muscarinic acetylcholine receptors. This was surprising, they said, because acetylcholine is a neurotransmitter usually associated with activation of cells.

With identification of this signaling pathway, the scientists suggest it is now possible to investigate the utility of antimuscarinic drugs already approved for use in other conditions as a new treatment for peripheral neuropathy.

“This is encouraging because the safety profile of antimuscarinic drugs is well characterized, with more than 20 years of clinical application for a variety of indications in Europe,” said senior study author Paul Fernyhough, Ph.D., professor in the departments of pharmacology and therapeutics and physiology at the University of Manitoba in Canada. “The novel therapeutic application of antimuscarinic antagonists suggested by our studies could potentially translate relatively rapidly to clinical use.”

WinSanTor is a clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies. We believe in creating a solution that works and brings relief to millions that are struggling with this disease. Learn more about our companyour drug and subscribe to our newsletter.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Sign up for our newsletter

Free to join.

Your privacy is very important to us. We will never share your information without your written consent.

WinSanTor is based in San Diego, California, USA

Share This Story, Choose Your Platform!

Related Posts

3d illustration of neuron cells with light pulses on a dark background.
Neuropathy

What Are Peripheral Nerves?

Our nervous system consists of the central and peripheral nervous system. Peripheral neuropathy is a condition involving damage to the peripheral nerves. So, what are peripheral nerves? Let’s look inside a

Shot of a senior man working out with dumbbells
Neuropathy

Exercising With Peripheral Neuropathy

Exercising with peripheral neuropathy can be challenging, as individuals may experience enhanced pain or numbness in their extremities during physical activity. Despite these difficulties, it is important to pursue physical

Have you been diagnosed with peripheral neuropathy? We can help.